Pulmonary fibrosis associated with ANCA-positive vasculitides. Retrospective study of 12 cases and review of the literature

Annals of the Rheumatic Diseases

Volumn 68, Issue 3, 2009, Pages 404-407

  Hervier, B ^a   Pagnoux, C ^b   Agard, C ^a   Haroche, J ^c   Amoura, Z ^c   Guillevin, L ^b   Hamidou, M A ^a  

^a NANTES UNIVERSITY HOSPITAL   (France)

^b Hôpital Cochin ^*  (France)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; MYELOPEROXIDASE; NEUTROPHIL CYTOPLASMIC ANTIBODY; STEROID;

ADULT; AGED; ANCA ASSOCIATED VASCULITIS; ARTICLE; CAUSE OF DEATH; CLINICAL ARTICLE; DISEASE ASSOCIATION; DISEASE EXACERBATION; EOSINOPHILIA; FEMALE; FOLLOW UP; HUMAN; LUNG FIBROSIS; LUNG HEMORRHAGE; MALE; PRIORITY JOURNAL; RESPIRATORY FAILURE; RESPIRATORY FUNCTION; RETROSPECTIVE STUDY;

AGED; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; AUTOIMMUNE DISEASES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PULMONARY FIBROSIS; RETROSPECTIVE STUDIES; VASCULITIS;

EID: 61449268071     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/ard.2008.096131     Document Type: Article

References (15)

1. American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS). Am J Respir Crit Care Med 2000;161 (Pt 1) :646-64.
2. Homma S, Matsushita H, Nakata K. Pulmonary fibrosis in myeloperoxidase antlneutrophil cytoplasmic antibody-associated vasculites. Respirology 2004;9:190-6.
3. Vassilopoulos D, Niles JL, Villa-Forte A, Arroliga AC, Sullivan EJ, Merkel PA, et al. Prevalence of antineutrophll cytoplasmic antibodies In patients with various pulmonary diseases or multiorgan dysfunction. Arthritis Rheum 2003;49:151-5.
4. Jennette JC, Falk RJ, Andrassy K, Bacon PA, Churg J, Gross WL, et al. Nomenclature of systemic vasculites. Proposal of an international consensus conference. Arthritis Rheum 1994;37:187-92.
5. Becker-Merok A, Nossent JC, Ritland N. Fibrosing alveolitis predating microscopic polyangiltis. Scand J Rheumatol 1999;28:254-6.
6. Birnbaum J, Danoff S, Askin FB, Stone JH. Microscopic polyanglitls presenting as a "pulmonary-muscle" syndrome: is subclinical alveolar hemorrhage the mechanism of pulmonary fibrosis? Arthritis Rheum 2007;56:2065-71.
7. Eschun GM, Mink SN, Sharma S. Pulmonary interstitial fibrosis as a presenting manifestation In perinuclear antineutrophlllc cytoplasmic antibody microscopic polyanglitls. Chest 2003;123:297-301.
8. Hiromura K, Nojima Y, Kitahara T, Ueki K, Maezawa A, Kawai H, et al. Four cases of anti-myeloperoxidase antibody-related rapidly progressive glomerulonephritis during the course of idiopathic pulmonary fibrosis. Clin Nephrol 2000;53:384-9.
9. Mansi IA, Opran A, Sondhi D, Ayinia R, Rosner F. Microscopic polyangiltis presenting as idiopathic pulmonary fibrosis: is anti-neutrophilic cytoplasmic antibody testing indicated? Am J Med Sci 2001;321:201- 2.
10. Nada AK, Torres VE, Ryu JH, Lie JT, Holley KE. Pulmonary fibrosis as an unusual clinical manifestation of a pulmonary-renal vasculitis In elderly patients. Mayo Clin Proc 1990;65:847-56.
11. Souid M, Terkl NH, Nochy D, Hilllon D. Myeloperoxidase anti-neutrophil cytoplasmic autoantibodies (MPO-ANCA)-related rapidly progressive glomerulonephritis (RPGN) and pulmonary fibrosis (PF) with dissociated evolution. Clin Nephrol 2001;55:337-8.
12. Gaudin PB, Askin FB, Falk RJ, Jennette JC. The pathologic spectrum of pulmonary lesions in patients with anti-neutrophil cytoplasmic autoantibodies specific for anti-proteinase 3 and anti-myeloperoxidase. Am J Clin Pathol 1995;104:7-16.
13. Magro CM, Allen J, Pope-Harman A, Waldman WJ, Moh P, Rothrauff S, et al. The role of microvascular injury in the evolution of idiopathic pulmonary fibrosis. Am J Clin Pathol 2003;119:556-67.
14. Gindre D, Peyrol S, Raccurt M, Sommer P, Loire R, Grimaud JA, et al. Fibrosing vasculitis In Wegener's granulomatosis: ultrastructural and immunohlstochemical analysis of the vascular lesions. Virchows Arch 1995;427:385-93.
15. Foucher P, Heeringa P, Petersen AH, Huitema MG, Brouwer E, Tervaert JW, et al. Antimyeloperoxidase-associated lung disease. An experimental model. Am J Respir Crit Care Med 1999;160:987-94.